Health
Start-up awarded grant to develop contrast agent for early detection of liver disease – EurekAlert
Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Instit…
ATLANTA–Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver disease.
“We have been working on this breakthrough in the lab for several years,” said Yang. “This funding will help us to…
-
General18 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News17 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
Noosa News18 hours agoThe Best Things to Do in Brisbane This New Year’s Eve
-
Noosa News22 hours agoMary River cod thriving in Brisbane River catchment, century after relative went extinct